Study how cystic fibrosis meds move in pregnancy and breastfeeding
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study measures how CFTR medicine behaves in the body during pregnancy and after delivery while breastfeeding. The results may help confirm dosing and safety information for people with cystic fibrosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and age 18 or older
- You have a diagnosis of cystic fibrosis
- You are taking a CFTR modulator medicine during pregnancy
- You will be in the postpartum period and taking CFTR modulator medicine
- You plan to breastfeed (and have no medical reason you cannot)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows women with cystic fibrosis (CF) during pregnancy and after birth, and checks on their babies and young children. The goal is to learn more about how CF affects pregnancy and child development.
This study looks at how the cystic fibrosis medication Kaftrio works during pregnancy and after childbirth. It follows women with cystic fibrosis who are already taking Kaftrio and their newborn babies.
This study looks at how well CFTR-modulator medicines are working in people with cystic fibrosis, by checking specific “biomarkers” (measurable signals) in samples. Your care team may use the results to better understand how these medicines help, especially for certain CFTR changes.
This study tests new treatments for cystic fibrosis in people who cannot take or choose not to take current CFTR modulators. It aims to find better options for managing CF.
This trial tests how well cystic fibrosis (CF) medicine works for you using an “n-of-1” approach, meaning you try treatments in a structured, repeated way to see what helps you most. It may help your care team choose the best option for your specific CF genetics and health status.
This observational study follows people with cystic fibrosis (CF) to understand the long-term impact of CFTR modulator medicines. It may help researchers see how these treatments work over time in real life.
Hear when a new Cystic Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.